John Markels, Director at SANGAMO THERAPEUTICS, INC (SGMO), bought 6,784 shares at $3.69 ($25K) on 2022-06-03, disclosed to the SEC on 2022-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.